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Abstract: The quality of the patient-provider relationship is regarded as an
essential ingredient in the treatment of serious mental illnesses, and is
associated with favorable outcomes including improved treatment adherence.
However, monitoring the strength and influence of provider support in
clinical settings is challenged by the absence of brief, psychometrically
sound, and easily administered assessments. The purpose of this study was to
test the factor structure and examine the clinical and psychosocial correlates
of a brief measure of provider support. Participants were recruited from the
continuous improvement for veterans in care—Mood Disorders study (N 
429). The hypothesized factor structure exhibited a good fit with the data. At
baseline, provider support was associated with higher levels of service access
and medication compliance and lower levels of alcohol use and suicidality.
Regular monitoring of provider support may provide useful when tailoring
psychosocial treatment strategies, especially in routine care settings.
Key Words: Provider support, therapeutic alliance, factor analysis, mood
disorders-bipolar, veterans.
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A growing number of studies are establishing a direct link be-tween the patient-provider relationship and a variety of out-
comes among individuals with bipolar disorder, including primary
care attendance, psychotherapy retention, and improved symptoms
(Berk et al., 2004; Gaudiano and Miller, 2006; Sajatovic et al.,
2005). Given these optimistic findings, the beneficial nature of
effective clinical relationships has been aptly coined as an effective
“mood stabilizer” (Havens and Ghaemi, 2005) and a critical goal in
psychotherapy (Summers and Barber, 2003). Furthermore, in de-
signing appropriate efforts to increase the strength of therapeutic
relationships, certain patients may garner particular advantages from
positive clinical interactions, such as ethnic minorities who endorse
different sets of culturally-based values and treatment perceptions,
and might benefit more from their clinical relationships than white
patients (Fleck et al., 2005; Tonigan, 2003). Recent studies have echoed
these observations, noting that efforts to translate the concept of better
provider support into the clinical setting requires a greater understand-
ing of cultural values and treatment preferences, along with practical
tools to measure such patient perceptions (Vasquez, 2007).
Recent research has linked patient perceptions of provider
support with medication adherence among individuals with bipolar
disorder (Zeber et al., 2007). Poor adherence is a common problem
among patients with this disorder (Lingam and Scott, 2002), result-
ing in numerous adverse clinical and behavioral outcomes (Post et
al., 2003; Salloum et al., 2005; Scott and Pope, 2002). Such findings
underscore the importance of monitoring and recognizing the quality
of patient-provider relationship in the treatment of bipolar disorder.
In particular, the patient-provider relationship is a key factor in
achieving a variety of intermediary outcomes (e.g., medication or
psychosocial treatment adherence), fundamental to achieving a va-
riety of long-term clinical outcomes.
This line of research also suggests that mental health provid-
ers should consider the quality of this relationship as a vital process
measure necessary to achieving desired clinical outcomes. To min-
imize the burden of collecting and interpreting data, especially in
routine care practice, instruments that measure the quality of the
provider-patient relationship should be brief, easy to administer, and
psychometrically sound. Although there are a variety of therapeutic
alliance scales described in the psychotherapy literature, (Martin,
2000) most are lengthy and hence impractical for routine care
settings, or were not designed specifically for individuals with
serious mental illnesses, especially bipolar disorder. A recent review
of the literature revealed that only a small number of psychometri-
cally sound tools are available for the assessment of bipolar disorder
related to screening, diagnosis, and long-term monitoring (Baldas-
sano, 2005). There is also a general absence of measures that focus
specifically on the patient perceptions of provider support for indi-
viduals with bipolar disorder.
Recently, the Health Care Climate Questionnaire (HCCQ)
was developed by Ludman et al. to fill this gap (Ludman et al.,
2002). The HCCQ is a 10-item instrument, designed to measure an
aspect of the patient-provider relationship called “provider support.”
Provider support refers to the extent to which health care providers
acknowledge and support patients’ self-management of chronic
illness (Ludman et al., 2002). This measure was developed by
combining 5 generic items of an existing measure assessing percep-
tion of providers’ autonomy (supportive versus controlling style) in
general health care treatment (Williams et al., 1996). Another 5
items related specifically to the self-management of bipolar disorder
were theoretically derived and included. Thus, it is a measure
specific to bipolar disorder but the language is general to make it
potentially useful for a broad range of serious mental illnesses.
Examples of items on the HCCQ include “I feel understood by my
mental health team” and “I am encouraged to ask questions about
my treatment.” Each question has a 7-point Likert scale response
option (from 0  strongly disagree to 6  strongly agree).
The concept of provider support can be considered related to
the more general construct referred to as “therapeutic alliance.” A
seminal article by Bordin (1979) defined alliance as a partnership
between the client and counselor based on their agreement on the
goals and tasks of counseling (Kivlighan, 2007). However, since this
seminal article, it has been described, defined, and measured in a
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variety of ways (Martin et al., 2000). As indicated by Martin et al.,
(2000) therapeutic alliance is commonly referred to as a single
construct, but the literature shows that it consists of several inde-
pendent dimensions. The HCCQ is unique because it focuses spe-
cifically on the bipolar patient’s perception of feeling acknowledged
and supported by the health care provider in illness self-manage-
ment. It is related to therapeutic alliance, as this type of support is
critical for developing the bond between the patient and provider.
To date, only 1 psychometric investigation of the HCCQ has
been conducted (Ludman et al., 2002). This study included bipolar
patients from 4 outpatient mental health clinics. An exploratory
factor analysis indicated that the HCCQ was unidimenionsal. Unro-
tated factor loadings ranged from 0.75 to 0.85, and item to “deleted
item total” correlations ranged from 0.73 to 0.83. The measure
exhibited a high level of internal consistency (alpha  0.94) (Lud-
man et al., 2002), and the measure was positively correlated with
self-efficacy for managing bipolar disorder (r  0.34) (Ludman et
al., 2002), and negatively associated with ratings of mania (r 
0.11), and depression (r  0.09). Overall, the preliminary
findings suggest that the HCCQ has good face validity, criterion
validity, and internal consistency. Clinical reports also indicate that
the measure is easy to use and score, making it an excellent
candidate for future psychometric investigations.
Overall, this measure shows considerable promise as a tool
for advancing research on the patient-provider relationship in the
treatment of bipolar disorders and serving as a process measure for
care provided in clinical settings. However, at present, the only
psychometric data available for the HCCQ are Cronbach’s  (reli-
ability) and exploratory factor analysis. What is missing is a specific
test of the factor structure in the way it is currently used. Moreover,
the HCCQ has been evaluated in only clinical trial settings. Brief
assessments such as the HCCQ, if shown to be valid or reliable in a
more naturalistic, generalizable cohort of patients, can be valuable
tool for gauging the impact of interventions or psychosocial treat-
ment strategies in a relatively short period of time without having to
wait years for longer-term outcome data to be ascertained.
The purpose of this study has 2 objectives. The first goal is to
extend the currently limited knowledge on the psychometrics of this
measure by examining the properties using confirmatory factor
analysis (CFA). This analytic methodology is superior to explor-
atory techniques that have been applied in the prior research.
Specifically, CFA provides a test of significance for a hypothesized
factor structure, while taking into account measurement error (Schu-
macker and Lomax, 2004). The second objective is to examine the
concurrent and predictive associations between this measure and
other service-related and clinical outcomes, notably adherence, ac-
cess to care, and health-related quality of life. Doing so contributes
greater knowledge to criterion-related validity, in addition to ex-
panding our understanding of the patient-provider relationship in the
treatment of bipolar disorder.
METHODS
Study Population and Sample
Participants were recruited from the Continuous Improve-
ment for Veterans in Care—Mood Disorders (CIVIC-MD) (Kil-
bourne et al., 2007). The CIVIC-MD is a naturalistic cohort study of
435 patients diagnosed with bipolar disorder recruited from a large
urban VA mental health facility in the mid-Atlantic region. Details
regarding the CIVIC-MD study are available elsewhere (Kilbourne
et al., 2008). In brief, the aim of CIVIC-MD was to examine patient
and provider factors associated with treatment quality and outcomes,
along with important mediators of these outcomes. Eligible patients
were currently receiving inpatient or outpatient treatment for bipolar
disorder from July 2004 through July 2006. Inclusion criteria in-
cluded a current diagnosis of bipolar disorder (I, II, NOS), cyclo-
thymia, or schizoaffective disorder-bipolar subtype based upon chart
review and provider confirmation. Patients self-completed a survey
that included questions regarding demographics and other patient
characteristics, symptomatology, substance use, behavioral factors,
access issues, and treatment adherence. The study was reviewed and
approved by the medical center Institutional Review Board. The
effective sample size for the current study was N  429.
Measurement Description
Internal States Scale
The Internal States Scale (ISS) is a 15-item measure using an
11-piont rating scale designed to elicit self-reports of mood states.
This measure does not assume that all manic or hypomanic episodes
are euphoric, but recognizes mixed states and depressive symptoms
during manic and hypomanic episodes. Sample items include, “To-
day I feel impulsive,” “Today my thoughts are going fast,” and
“Today I feel depressed.” Prior research has revealed that the ISS is
composed of 4 subscales: Activation (5 items), wellbeing (3 items),
depression (2 items), and perceived conflict (5 items). Activation
and wellbeing are used to discriminate mood states (euthymia vs.
manic or hypomania vs. mixed vs. depression). Activation reflects
manic symptoms, depression reflects depressive symptoms, and
perceived conflict is a global score of psychopathology. Earlier
studies have revealed that the ISS has good psychometric properties,
including high interitem consistency, test-retest reliability, and val-
idation against clinician rated symptom severity (Bauer et al., 1991;
Bauer et al., 2000; Cooke et al., 1996).
Medication Compliance
Medication compliance was assessed using the validated
Morisky scale (Morisky et al., 1986), a 4-item yes or no instrument
frequently used for adherence research across a variety of chronic
medical and psychiatric conditions, including affective disorders
(George et al., 2000; Shalansky et al., 2004). The items included
forgetting to take medications, carelessness at time, stop taking
medications when feeling better, and stop taking medications when
feeling worse. The 4 items were summed, with higher scores
reflecting greater levels of compliance. Recent research has shown
this scale to have good reliability (  0.83), concurrent and
predictive validity in outpatient settings (Morisky et al., 2008;
Morisky et al., 1986).
Service Sccess
Access to VA psychiatric and medical services was assessed
using 6 items, which was based on a prior service access study (see
Cunningham, 1995). The items addressed dimensions of access and
perceived difficulties obtaining care when needed. All questions
were measured using a 5-point Likert-type scale (strongly agree to
strongly disagree).
Health-Related Quality of Life
Health-related quality of life was measured using a single
item from the 12-item Short-Form Health Survey (SF-12; Ware et
al., 1995; Ware et al., 1996), which asked participants to rate their
overall health on a 5-point Likert-type scale (excellent to poor).
Substance Use
Participants were asked to report past year use of substances.
Alcohol use was measured on a 5-point ordinal scale (never use to
more than 4 times a week). Other illicit drug use, including mari-
juana, cocaine, hallucinogens, opiates, or stimulants, was measured
on a 4-point scale (have never tried to everyday). Participants were
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also asked the extent to which drugs interfered with work at school,
a job or at home. Responses were recorded on a 5-point scale (once
or twice to more than 20 times).
Suicidality
Suicidal ideation was measured using a single item from the
Patient Health Questionnaire-9; Kroenke et al., 2001; Spitzer et al.,
1999). Patients were asked how often in the last 2 weeks they had
“thoughts that you would be better off dead or of hurting yourself in
some way,” scored from “0” (not at all) to “3” (nearly every day).
The Patient Health Questionnaire-9 has exhibited good reliability,
convergent/discriminant validity, and responsiveness to change in
recent research (Cameron et al., 2008).
Analytic Plan
Correlational Analysis
Bivariate associations were conducted to examine the asso-
ciation between provider support and other psychosocial and clinical
measures, which are outlined below. These are predominately ordi-
nal-level measures. Therefore, a nonparametric correlation—that is,
the Spearmen rank order (i.e., nonparametric) correlation ()—was
used instead of the Pearson product moment correlation. All mea-
sures described were administered at baseline and are included in the
correlational analysis. However, the HCCQ and other measures (i.e.,
service access, different types of drug use, and medical comorbidi-
ties) were not included in the follow-up survey. All correlations
were interpreted as effect sizes using the general guidelines offered
by Cohen (1962), where 0.20 is a small effect size, 0.50 is medium,
and 0.80 is large.
Confirmatory Factor Analysis
The analytic strategy for examining the factor structure of the
HCCQ was CFA, which was performed using LISREL version 8.80.
CFA provides a test of significance to determine whether the sample
data confirms the model (Schumacker and Lomax, 2004). This method
helps to rule out the possibility that the results of exploratory factor
analysis were due to chance. This is an important method for establish-
ing the reliability and validity of this measure of provider support.
A preliminary analysis of the data revealed that the items of
the HCCQ were skewed, with skewness values ranging from 0.3
to 0.9. Therefore, weighted least squares estimation was used, as
opposed to maximum likelihood estimation which requires that data
are normally distributed. The adequacy of the models were selected
using commonly used measures of fit including the chi square (chi
square) test, the normed fit index, root-mean-square error of approx-
imation (RMSEA), comparative fit index, incremental fit index, and
degrees of chi square to degrees of freedom ratio.
RESULTS
Sample Characteristics
Table 1 provides a summary of the study sample characteristics.
The mean age of the study population was 49.4 years (SD  10.6), with
14% women and 23% ethnic minorities (including 13% African-
Americans), a profile well representative of all veterans diagnosed with
bipolar disorder (Blow et al., 2005). Approximately 66% attended at
least some college. Substance use problems were highly prevalent, with
28% reporting some past-year drug use and 21% reporting past-year
hazardous drinking. About 30% of this sample had a recent manic
episode, and 12% reported being homeless.
HCCQ Summary
Summary statistics for the HCCQ items is presented in Table
2. The individual item means ranged from 4.42 to 5.19. The overall
mean score across all 10 items was 39.4 (SD  15.0), which
indicated that subjects had a slightly positive overall view of
provider support and comfort within their mental health treatment
environment. Interitem associations ranged from 0.63 to 0.87. In-
ternal consistency of the HCCQ, as measured by Cronbach’s , was
high (  0.95).
TABLE 1. Socio-Demographic, Psychosocial, and Clinical










African American 58 (13)
Other 41 (9)




























ISS–well-being Range  0–300
Mean  151.6
SD  78.5
ISS–activation Range  0–490
Mean  186.4
SD  130.0
ISS–Depression Range  0–200
Mean  61.7
SD  61.7
ISS–Personal conflict Range  0–500
Mean  132.9
SD  120.3
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Confirmatory Factor Analysis
The factor structure of the HCCQ was tested using CFA. The
chi square value was significant (chi square 35  128.6, p 
0.001), and the chi square degrees of freedom value (3.6) was
slightly above the generally accepted level, suggesting some misfit
between the data and the hypothesized factor structure. However, all
remaining goodness of fit indices provided evidence of an accept-
able fit. More specifically, the normed fit index value was 0.99,
reflecting a 99% improvement over the null model (Klein et al.,
2003). The comparative fit index and incremental fit index values
were also equal to 0.99. The RMSEA was also at a level of
acceptable fit (RMSEA  0.079).
Figure 1 is a path diagram showing the individual factor
loadings and the reliability estimates of the overall model. All factor
loadings were statistically significant, ranging from 0.87 to 0.98.
Additional sensitivity analyses were conducted by excluding various
items that exhibited lower factor loading relative to the other items.
A superior fit to the single factor approach was not achieved. Taken
together, these analyses suggest that the 10 items of the HCCQ are
strong indicators of provider support as it has been used in prior
studies (Ludman et al., 2002; Zeber et al., 2007).
Associations Between Provider Support and
Demographic, Clinical, and Psychosocial Measures
Provider support was not associated with gender, race, marital
status, or age. However, respondents with some college education
had slightly higher provider support scores than those without
college education (Kruskal-Wallis chi square 1  3.86, p  0.049).
A series of correlations between provider support and other
psychosocial and clinical measures at baseline and follow-up were
examined, which are summarized in Table 3. Provider support was
not associated with ISS-Wellbeing at baseline or follow-up. How-
ever, it had relatively small negative associations with ISS-Activa-
tion, ISS-depression and ISS-perceived conflict at baseline and
follow-up. Medication adherence exhibited a significant association
but a small effect size with therapeutic alliance at baseline ( 
0.15, p  0.011), but not follow-up (  0.02, p  0.799). Service
access exhibited the strongest associations, ranging from   0.22
to 0.43 , and all were in the expected directions. These effect sizes
were small, and 2 approached a medium effect: ease of seeing a
specialist and services being accessible (  0.42 and 0.43, respec-
tively). Lower levels of alcohol use were associated with higher
levels of therapeutic alliance at baseline (  0.16), which was
also observed at follow-up. None of the other substances were
associated with therapeutic alliance. The number of medical comor-
bidities was also not associated with therapeutic alliance. Provider
support had a moderately small association with suicidality at baseline
(  0.28) and a weaker association at follow-up (  0.17).
DISCUSSION
Prior research has used exploratory methods to examine the
psychometric properties of the HCCQ. This study extended our
knowledge regarding measurement of provider support, specifically
among providers and patients with bipolar disorder, by rigorously
testing the factor structure of the HCCQ using CFA. Overall, the
hypothesized factor structure exhibited a good fit with the data,
supporting the manner in which it has been used in prior studies
(Ludman et al., 2002; Zeber et al., 2007). Provider support scores
were also significantly correlated with numerous baseline measures,
TABLE 2. Provider Support Scale Items With Means, Standard Deviations, and Polychoric Correlations (N  429)
Item Mean (SD) Skew 1 2 3 4 5 6 7 8 9 10
I feel that my mental health care provider
team has provided me choices and
options.
5.14 (1.76) 0.77 1.0
I feel understood by my mental health care
provider team.
5.18 (1.75) 0.79 0.83 1.0
My mental health care provider team
conveys confidence in my ability to make
changes.
5.11 (1.68) 0.73 0.77 0.82 1.0
My mental health care provider team
encourages me to ask questions.
5.19 (1.82) 0.81 0.73 0.77 0.77 1.0
My mental health care provider team tries to
understand how I see things before
suggesting a new way of doing things.
5.11 (1.78) 0.74 0.76 0.84 0.79 0.83 1.0
My mental health care provider team made
me aware of what to expect from good
bipolar disorder care.
4.70 (1.83) 0.45 0.69 0.72 0.67 0.73 0.75 1.0
My mental health care provider team has
provided training in what I need to do to
carry out good bipolar disorder care.
4.51 (1.88) 0.36 0.62 0.67 0.63 0.68 0.73 0.87 1.0
My mental health care provider team
regularly reviews with me my progress in
managing all aspects of my treatment
plan.
4.72 (1.79) 0.48 0.70 0.72 0.67 0.72 0.77 0.79 0.83 1.0
My mental health care provider team has
worked with me to develop a bipolar
disorder care plan.
4.42 (1.92) 0.30 0.62 0.67 0.64 0.66 0.70 0.80 0.89 0.82 1.0
My mental health care provider team makes
sure that we stay in regular contact.
5.33 (1.78) 0.90 0.62 0.69 0.64 0.64 0.72 0.65 0.63 0.74 0.65 1.0
Covariances are located on the diagonal of the matrix.
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including medication adherence 6 different dimensions of service
access, health-related quality of life, alcohol use, and suicidality.
With the exception of medication adherence, the measures used at
1-year follow-up (i.e., health related quality of life, alcohol use, and
suicidality) were also exhibited significant associations. Service
access exhibited the strongest associations with provider support,
and the effect sizes with the other psychosocial and clinical variables
were fairly small, but all were in the expected direction. This type of
correlational pattern in the social and behavioral sciences is typical
and reflects the difficulty of developing intervention strategies that
have large effects. Provider support was not associated with the use
of other substances assessed (i.e., marijuana/hash, cocaine/crack,
stimulants, opioids, and other drugs), which may be attributed to the
low base rate of use.
Strengths of this study include using a confirmatory approach
to examining the structure of the HCCQ among a large sample of
individuals with bipolar disorder. It is also important to note the
limitation of the sample being derived from a single medical center
within the Department of Veterans Affairs, the sample is fairly
homogenous, representing primarily white middle-aged males of
lower socio-economic status. Yet we note that this cohort is remark-
ably similar to the entire population of nearly 72,000 veterans with
bipolar disorder treated in the VA during 2004 (Blow et al., 2005).
Thus, while our patient sample may represent those with the greatest
service needs, it is important to be cautious in generalizing these
findings across all patient populations with mental disorders.
The results of this study should also be considered in context
of its limitations. The HCCQ was not administered at follow-up, so
it was not possible to directly test the stability of the measure over
time. However, many of the correlations with the HCCQ at baseline
and follow-up remained stable, suggesting that it is a fairly stable
measure. While provider support has many similarities with the
concept of therapeutic alliance, this study did not include any
standardized measure of therapeutic alliance to help understand the
extent to which these constructs overlap. Addressing this issue will
be an important next step to establishing the validity of this measure
and the broader theoretical literature on therapeutic alliance, pro-
vider support, and related constructs.
Overall, this study adds to the existing evidence that the HCCQ
instrument is a reliable and valid measure of provider support, which
can be useful for both research and clinical purposes. This is particularly
important given an increasing emphasis of targeting the patient’s
comfort in their own mental health care environment, including their
perceptions of adopting an empowered active role in their own treat-
ment plan and improving subsequent outcomes (Kim et al., 2008; Mead
and Bower, 2000). Given the administrative demands that clinicians
often face, it is important that they are equipped with brief measures that
are easy to administer and interpret to increase the likelihood they will
use process data to guide treatment.
The HCCQ also exhibited numerous associations with key
psychosocial and clinical variables. For example, at baseline, pro-
vider support was significantly associated with higher levels of
medication compliance and lower levels of alcohol use. This sug-
FIGURE 1. Factor loadings and reliability estimate of the
HCCQ.
TABLE 3. Bivariate Associations Between Therapeutic




 p  p
Internal states scale
Well-being 0.09 0.064 0.065 0.236
Activation 0.21 0.001 0.18 0.001
Depression 0.16 0.001 0.20 0.001
Perceived conflict 0.19 0.001 0.13 0.018




0.28 0.001 — —
Hard to get into
emergency room
0.30 0.001 — —
Too expensive 0.22 0.001 — —
Easy to see a specialist 0.42 0.001 — —
Easy to get to facilities 0.28 0.001 — —
Available anywhere 0.43 0.001 — —
Health related quality
of life
0.11 0.051 0.16 0.005
Substance use
Alcohol use 0.16 0.004 0.16 0.005
Marijuana/hash 0.03 0.566 — —
Cocaine/crack 0.04 0.434 — —
Stimulants 0.05 0.392 — —
Opioids 0.04 0.472 — —
Other drugs 0.02 0.682 — —
Use of substances cause
life interference
0.14 0.010 — —
No. medical comorbidities 0.04 0.530 — —
Suicidality 0.28 0.001 0.17 0.003
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gests that provider support may contribute to client motivation and
engagement. At the same time, the causal associations are unclear.
For example, clients who use less alcohol may have greater capacity
to benefit from the treatment process, which may lead to greater
levels of perceived support. Similarly, service access was also
associated with provider support, which suggests that the HCCQ
could be a measure that is influenced by both the clinical process and
the broader program or organizational environment. This is consis-
tent with current research initiatives examining the role of organi-
zational factors on client satisfaction, engagement, and perceptions
of care (Broome et al., 2007; Lehman et al., 2002). The directions of
causality may be uncovered through causal modeling techniques
(e.g., structural equation modeling) and longitudinal study designs.
Future research on the HCCQ could benefit from examining
the factor structure using samples with greater levels of diversity,
and examining a wider range of associations with clinical and
psychosocial measures over time. This would allow the opportunity
to examine the factor structure across various socio-demographic
groups and reveal the stability of associations. Although this mea-
sure was designed specifically for individuals with bipolar disorder,
this measure can be potentially useful with other serious mental
illnesses. Future research should also focus on the application of the
HCCQ as a process measure in evaluation and clinical research, to
monitor improvements in provider support over time.
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